Background: The prognostic weight of further decompensation in cirrhosis is still unclear. We investigated the incidence of further decompensation and its effect on mortality in patients with cirrhosis.Methods: Multicenter cohort study. The cumulative incidence of further decompensation (development of a second event or complication of a decompensating event) was assessed using competing risks analysis in 2028 patients. A four-state model was built: first decompensation, further decompensation, liver transplant, death. A cause-specific Cox model was used to assess the adjusted effect of further decompensation on mortality. Sensitivity analyses were performed for patients included before or after 1999. Results: In a mean follow-up of 43 months, 1192 patients developed further decompensation and 649 died. Corresponding 5-year cumulative incidences were 52% and 35%, respectively. The cumulative incidences of death and liver transplant after further decompensation were 55% and 9.7%, respectively. The most common further decompensating event was ascites/complications of ascites. Five-year probabilities of state occupation were: 24% alive with first decompensation, 21% alive with further decompensation, 7% alive with liver transplant, 16% dead after first decompensation without further decompensation, 31% dead after further decompensation, and <1% dead after liver transplant. The hazard ratio for death after further decompensation adjusted for known prognostic indicators, was 1.46 (95% CI 1.23-1-711) (p<0.001). The significant impact of further decompensation on survival was confirmed in patients included before or after 1999. Conclusion: In cirrhosis, further decompensation occurs in approximately 60% of patients, significantly increases mortality, and should be considered a more advanced stage of decompensated cirrhosis.
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements / D'Amico, Gennaro; Zipprich, Alexander; Villanueva, Càndid; Sordà, Juan Antonio; Morillas, Rosa Maria; Garcovich, Matteo; García Retortillo, Montserrat; Martinez, Javier; Calès, Paul; D'Amico, Mario; Dollinger, Matthias; García-Guix, Marta; Gonzalez Ballerga, Esteban; Tsochatzis, Emmanuel; Cirera, Isabel; Albillos, Agustìn; Roquin, Guillaume; Pasta, Linda; Colomo, Alan; Daruich, Jorge; Canete, Nuria; Boursier, Jérôme; Dallio, Marcello; Gasbarrini, Antonio; Iacobellis, Angelo; Gobbo, Giulia; Merli, Manuela; Federico, Alessandro; Svegliati Baroni, Gianluca; Pozzoni, Pietro; Addario, Luigi; Chessa, Luchino; Ridola, Lorenzo; Garcia-Tsao, Guadalupe. - In: HEPATOLOGY. - ISSN 1527-3350. - 79:4(2024), pp. 869-881. [10.1097/HEP.0000000000000652]
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements
Svegliati Baroni, Gianluca;
2024-01-01
Abstract
Background: The prognostic weight of further decompensation in cirrhosis is still unclear. We investigated the incidence of further decompensation and its effect on mortality in patients with cirrhosis.Methods: Multicenter cohort study. The cumulative incidence of further decompensation (development of a second event or complication of a decompensating event) was assessed using competing risks analysis in 2028 patients. A four-state model was built: first decompensation, further decompensation, liver transplant, death. A cause-specific Cox model was used to assess the adjusted effect of further decompensation on mortality. Sensitivity analyses were performed for patients included before or after 1999. Results: In a mean follow-up of 43 months, 1192 patients developed further decompensation and 649 died. Corresponding 5-year cumulative incidences were 52% and 35%, respectively. The cumulative incidences of death and liver transplant after further decompensation were 55% and 9.7%, respectively. The most common further decompensating event was ascites/complications of ascites. Five-year probabilities of state occupation were: 24% alive with first decompensation, 21% alive with further decompensation, 7% alive with liver transplant, 16% dead after first decompensation without further decompensation, 31% dead after further decompensation, and <1% dead after liver transplant. The hazard ratio for death after further decompensation adjusted for known prognostic indicators, was 1.46 (95% CI 1.23-1-711) (p<0.001). The significant impact of further decompensation on survival was confirmed in patients included before or after 1999. Conclusion: In cirrhosis, further decompensation occurs in approximately 60% of patients, significantly increases mortality, and should be considered a more advanced stage of decompensated cirrhosis.File | Dimensione | Formato | |
---|---|---|---|
D'Amico_Further-decompensation-cirrhosis_Post-print_2024.pdf
Solo gestori archivio
Descrizione: This is an Accepted Manuscript version of the following article, accepted for publication in HEPATOLOGY: Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements / D'Amico, Gennaro; Zipprich, Alexander; Villanueva, Càndid; Sordà, Juan Antonio; Morillas, Rosa Maria; Garcovich, Matteo; García Retortillo, Montserrat; Martinez, Javier; Calès, Paul; D'Amico, Mario; Dollinger, Matthias; García-Guix, Marta; Gonzalez Ballerga, Esteban; Tsochatzis, Emmanuel; Cirera, Isabel; Albillos, Agustìn; Roquin, Guillaume; Pasta, Linda; Colomo, Alan; Daruich, Jorge; Canete, Nuria; Boursier, Jérôme; Dallio, Marcello; Gasbarrini, Antonio; Iacobellis, Angelo; Gobbo, Giulia; Merli, Manuela; Federico, Alessandro; Svegliati Baroni, Gianluca; Pozzoni, Pietro; Addario, Luigi; Chessa, Luchino; Ridola, Lorenzo; Garcia-Tsao, Guadalupe. - In: HEPATOLOGY. - ISSN 1527-3350. - 79:4(2024), pp. 869-881. [10.1097/HEP.0000000000000652].
Tipologia:
Documento in post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza d'uso:
Tutti i diritti riservati
Dimensione
382.16 kB
Formato
Adobe PDF
|
382.16 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.